MedTrace Logo

Efficacy of Acyclovir in Combination With a Glucocorticosteroid on UV-Induced Herpes Labialis

NCT00736437 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 417

Last updated 2008-08-15

No results posted yet for this study

Summary

The primary objective was to compare the efficacy of ME-609 cream vs placebo cream on the time to healing (loss of hard crust) of delayed classical herpes labialis (HSV) lesions experimentally induced after ultra violet radiation (UVR) exposure.

Conditions

  • Herpes Labialis

Interventions

DRUG

ME-609

Cream applied topically 6 times daily over the UVR exposed area

DRUG

Vehicle

Treatment applied 6 times daily over the UVR exposed area

Sponsors & Collaborators

  • Medivir

    lead INDUSTRY

Principal Investigators

  • Spotswood L Spruance, MD · University of Utah

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1999-08-31
Primary Completion
2000-08-31
Completion
2000-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00736437 on ClinicalTrials.gov